August 27, 2021

Bux4Real

Business and Funding News

Attention investors: what are the most recommended actions of companies that fight against the pandemic

Attention investors: what are the most recommended actions of companies that fight against the pandemic
Flower
Flower

Various stocks of global companies listed on Wall Street and focused on biotechnology are watched closely by analysts

The expansion of the Delta variant of Covid In several countries that thought they had the pandemic under control, it puts the world on alert regarding the duration of this great health problem that affects the economy.

In this sense, investors are seeing that one of the great “favored” of this context is the industry of biotechnology, as is the case with laboratories that develop vaccines and drugs to treat new varieties of coronavirus.

In this regard, there are several shares of companies in this sector They have prospects for further growth, and which a small saver can access since they are listed in dollars on Wall Street. So you can buy these papers from Argentina, through a local broker and with an account in dollars.

Biotech companies use the processes carried out by living organisms to make products that serve to solve certain problems. For example, “DNA identification and procurement has helped the industry make great strides,” indicates a report from IOL InvestOnline.

The letter adds that companies in this sector have developed from crops resistant to pests to vaccines against various diseases.

To get an idea, biotech companiesa, in general, they have very high operating costs, since they are involved in the entire chain that leads to creating an innovative product, such as research, development and testing.

All these steps it takes many years to be completed and provide results, which can lead to a historic breakthrough, or can also fail and be forgotten.

Shares in biotech companies can be a good alternative to earn in dollars in the context of a pandemic.

Recommended biotechnological actions

In this regard, a report from the investment firm IOL invertirOnline, details what the analysts most innovative biotech companies last year, and what Due to the current pandemic situation, they can represent a good opportunity to bet on them.

The selected firms that are linked to vaccines and other medicinal developments that would allow to obtain interesting profits in dollars, according to this writing, are:

Pfizer-Biontech (NYSE: PFE)

Pfizer is the company that “leads this list for being one of the first to commercialize an effective Covid-19 vaccine. “

It even details that, without the help of Operation Warp Speed, New York-based drug maker Pfizer and German manufacturing partner BioNTech “They managed to deliver a vaccine in record time, obtaining from the FDA the Emergency Use Authorization (EAU, for its acronym in English) in the United States,” they say from IOL.

In addition, it is noted that these firms achieved distribute millions of doses in less than a year, after the genetic sequence of Covid-19 was first obtained.

In fact, it is the first mRNA vaccine approved for any disease, and it had a 95% effectiveness after two doses in the trials.

Moderna (Nasdaq: MRNA)

Also highlighted is Modern, because a week after the authorization of Pfizer, the FDA granted its second EUA for a Covid-19 vaccine to the injection of this firm, which is based in Cambridge, Massachusetts (United States), which “had a effectiveness greater than 94% in rehearsals. ”

“Like the Pfizer vaccine, the mRNA vaccine Moderna requires two inoculations. But it can store in a normal freezer, while the Pfizer vaccine should be kept at minus 94ºF. Moderna has several other vaccines and mRNA therapies in phase 1 or 2 trials “, encourage from IOL.

Astrazeneca (Nasdaq: AZN)

Unlike the Moderna and Pfizer vaccines, which use mRNA to convince cells to produce a Covid-19 spike protein, the Oxford-AstraZeneca vaccine uses hidden DNA inside a chimpanzee cold virus, which is engineered to trick cells into producing coronavirus antigens.

The report details that the DNA-based vaccine does not need to be frozen and can refrigerate up to six months. It was approved in the UK in December, and remains viable for six months with standard refrigeration.

Stocks of Wall Street-traded labs may continue to rise due to the spread of the Delta variant of Covid-19.

Stocks of Wall Street-traded laboratories may continue to rise in price due to the spread of the Delta variant of Covid-19.

Twist Bioscience (Nasdaq: TWST)

The American company is one of the leading synthetic DNA manufacturers for industrial and research uses.

In 2020, when the pandemic was in full swing, he managed to adapt his method to produce More delicate RNA.

“He quickly developed a synthetic control version of the Covid-19 virus, which has been used by numerous laboratories to develop and validate tests and antibodies to the virus, without the risk of exposure to the virus itself,” say IOL stock market analysts. .

Twist also presented his Respiratory virus panel, which detects Covid-19, MERS, SARS and other strains of coronavirus, influenza, pneumonia, among others.

Glaxosmithkline (NYSE: GSK)

In the last two years, GlaxoSmithKline has obtained one more dozen new approvals for drugs and vaccines. In fact, it presented 9 developments in 2020 alone.

“He demonstrated his commitment to the development of genetically validated drugs. Recently, GSX has partnered with pioneers in CRISPR, a very specific branch of DNA modification advancements, and is currently working on nearly 30 new simultaneous early discovery programs for cancer, neurological, cardiovascular disease. and metabolic “, stand out from IOL investOnline.

Illumina (Nasdaq: ILMN)

It is a company that is dedicated to manufacture hardware and software for single cell analysis. This technology performs cellular shape analysis to detect abnormalities quickly, allowing, for example, the detection of cancers in early stages.

“In 2020, it had 250 patents issued and 500 pending approval. A new spatial molecular profiling tool allows researchers to see how cells organize themselves, to create maps of gene expression in a tumor or tissue sample and to develop highly specific new treatments, “the report relates.

Gilead (Nasdaq: GILD)

Finally, Gilead is a American biopharmaceutical company based in Foster City, California, which focuses on the research and development of antiviral medications, which are used in the treatment of HIV, hepatitis B, hepatitis C and influenza.

In addition, it is currently also noted for the development and research of different oncological treatments, concludes the IOL analysis.

Know the value of the dollar in Dollar Today and followed the price and behavior minute by minute. CLICK HERE